Efficacy and safety of chloramphenicol: Joining the revival of old antibiotics? Systematic review and meta-analysis of randomized controlled trials

Journal of Antimicrobial Chemotherapy

Volumn 70, Issue 4, 2014, Pages 979-996

  Eliakim Raz, Noa ^a,b   Lador, Adi ^a,b   Leibovici Weissman, Yaara ^a,b   Elbaz, Michal ^a,b   Paul, Mical ^b,c   Leibovici, Leonard ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c RAMBAM MEDICAL CENTER   (Israel)

Author keywords

CHL; Old broad spectrum antibiotic; RCTs

Indexed keywords

ANTIBIOTIC AGENT; CHLORAMPHENICOL; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT;

ANEMIA; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; DRUG EFFICACY; DRUG FATALITY; DRUG INDICATION; DRUG INDUSTRY; DRUG MARKETING; DRUG SAFETY; DRUG TREATMENT FAILURE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HEMATOLOGIC DISEASE; HUMAN; INFECTION RISK; MENINGITIS; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT INFECTION; SALMONELLOSIS; SEPSIS; SYSTEMATIC REVIEW; TYPHOID FEVER; BACTERIAL INFECTIONS; SURVIVAL ANALYSIS;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CHLORAMPHENICOL; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVAL ANALYSIS;

EID: 84926429227     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dku530     Document Type: Article

References (84)

1. Falagas ME, Kopterides P. Old antibiotics for infections in critically ill patients. Curr Opin Crit Care 2007; 13: 592-7.
2. Maviglia R, Nestorini R, Pennisi M. Role of antibiotics in multidrug resistant bacterial infections. Curr Trug Targets 2009; 10: 895-905.
3. Koup JR, Brodsky B, Lau A et al. High-performance liquid chromatographic assay of chloramphenicol in serum. Antimicrob Agents Chemother 1978; 14: 439-43.
4. Glazko AJ,Wolf LM. Biochemical studies on chloramphenicol; tissue distribution and excretion studies. J Pharmacol Exp Ther 1949; 96: 445-59.
5. Neu HC, Gootz TD. Antimicrobial chemotherapy: antimicrobial inhibitors of ribosome function. In: Baron S et al., eds. Baron's Medical Microbiology. 2nd edn. Galveston: University of Texas Medical Branch.
6. Bhutta ZA. Current concepts in the diagnosis and treatment of typhoid fever. BMJ 2006; 333: 78-82.
7. Parry CM. Untreatable infections?-The challenge of the 21st century. Southeast Asian J Trop Med Public Health 1998; 29: 416-24.
8. Karki S, Shakya P, Cheng AC et al. Trends of etiology and drug resistance in enteric fever in the last two decades in Nepal: a systematic review and meta-analysis. Clin Infect Dis 2013; 57: e167-76.
9. Holt R. The bacterial degradation of chloramphenicol. Lancet 1967; 1: 1259-60.
10. Brunton LL, Chabner BA, Knollmann BC. (eds). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 12th edn. New York, NY, USA: McGraw Hill, 2011.
11. Higgins JPT, Green S (eds). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. http://www.cochrane-handbook.org.
12. Asghar R, Banajeh S, Egas J et al. Chloramphenicol versus ampicillin plus gentamicin for community acquired very severe pneumonia among children aged 2-59 months in low resource settings: multicentre randomised controlled trial (SPEAR study). BMJ 2008; 336: 80-4.
13. Pines A, Greenfield JS, Raafat H et al. Chloramphenicol and ampicillin compared in elderly patients with severe purulent exacerbations of bronchitis. Br J Dis Chest 1972; 66: 116-20.
14. Pines A, Raafat H, Greenfield JSB et al. Antibiotic regimens in moderately ill patients with purulent exacerbations of chronic bronchitis. Br J Dis Chest 1972; 66: 107-15.
15. Duke T, Poka H, Dale F et al. Chloramphenicol versus benzylpenicillin and gentamicin for the treatment of severe pneumonia in children in Papua New Guinea: a randomised trial. Lancet 2002; 359: 474-80.
16. Cogo R, Ciampini M, Ceccarelli G. Cefatrizine therapy in respiratory infections: clinical activity and effects on secretory IgAs. Advances in Therapy 1990; 7: 169-74.
17. Pécoul B1, Varaine F, Keita M et al. Long-acting chloramphenicol versus intravenous ampicillin for treatment of bacterial meningitis. Lancet 1991; 338: 862-6.
18. Whittle HC, Davidson NM, Greenwood BM et al. Trial of chloramphenicol for meningitis in northern savanna of Africa. Br Med J 1973; 3: 379-81.
19. Peltola H, Anttila M, Renkonen OV. Randomised comparison of chloramphenicol, ampicillin, cefotaxime, and ceftriaxone for childhood bacterial meningitis. Finnish Study Group. Lancet 1989; 1: 1281-7.
20. Nathan N, Borel T, Djibo A et al. Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study. Lancet 2005; 366: 308-13.
21. Nelson KE, Levin S, Spies HWet al. Treatment of Hemophilus influenzae meningitis: a comparison of chloramphenicol and tetracycline. J Infect Dis 1972; 125: 459-65.
22. Cristiano P, Imparato L, Carpinelli C et al. Pefloxacin versus chloramphenicol in the therapy of typhoid fever. Infection 1995; 23: 103-6.
23. Kamat SA. Evaluation of therapeutic efficacy of trimethoprimsulphamethoxazole and chloramphenicol in enteric fever. Br Med J 1970; 3: 320-2.
24. Limson BM, Mendoza MT, Liwanag E et al. Randomised, comparative trial of mecillinam, mecillinam/ampicillin and chloramphenicol in the treatment of enteric fever. J Antimicrob Chemother 1982; 9: 405-10.
25. Morelli G, Guerriero M, Cristiano P et al. Cefoperazone compared with chloramphenicol in the treatment of typhoid fever. Chemotherapy 1988; 34: 71-6.
26. Pape JW, Gerdes H, Oriol L et al. Typhoid fever: successful therapy with cefoperazone. J Infect Dis 1986; 153: 272-6.
27. Pillay N, Adams EB, North-Coombes D. Comparative trial of amoxycillin and chloramphenicol in treatment of typhoid fever in adults. Lancet 1975; 7930: 333-4.
28. Sanders WL. Treatment of typhoid fever: a comparative trial of ampicillin and chloramphenicol. Br Med J 1965; 5472: 1226-7.
29. Robertson P, AbdelWahab MF, Raasch FO. Evaluation of chloramphenicol and ampicillin in salmonella enteric fever. NEJM 1968; 278: 171-6.
30. Abengowe CU. Comparative clinical trial of amoxicillin and chloramphenicol in the treatment of typhoid in adults. J Int Med Res 1979; 7: 247-52.
31. Acharya G, Butlet T, Ho M et al. Treatment of typhoid fever: randomized trial of a three-day course of ceftriaxone versus a fourteen-day course of chloramphenicol. Am J Trop Med Hvg 1995; 52: 162-5.
32. Akinkugbe OO, Lewis EA, Montefiore D et al. Trimethoprim and sulphamethoxazole in typhoid. Br Med J 1968; 5620: 721-2.
33. Arnold K, Hong CS, Nelwan R et al. Randomized comparative study of fleroxacin and chloramphenicol in typhoid fever. Am J Med 1993; 94: 195S-200S.
34. Carcelen A, Chirinos J, Yi A. Furazolidone and chloramphenicol for treatment of typhoid fever. Scand J Gastroenterol Suppl 1989; 169: 19-23.
35. Butler T, Rumans L, Arnold K. response of typhoid fever caused by chloramphenicol-susceptible and chloramphenicol-resistant strains of Salmonella Typhi to treatment with trimethoprim-sulfamethoxazole. Rev Infect Dis 1982; 4: 551-61.
36. Butler T, Sridhar CB, Daga MK et al. Treatment of typhoid fever with azithromycin versus chloramphenicol in a randomized multicentre trial in India. J Antimicrob Chemother 1999; 44: 243-50.
37. Cardoso N. Double blind trial with chloramphenicol and the combination trimethoprim/sulfamethoxazole in typhoid. S Afr Med J 1972; 46: 1286-7.
38. Damany SJ, Bilgi C. A comparative trial of furazolidone and chloramphenicol in typhoid fever. J Indian Med Assoc 1970; 55: 131-3.
39. Dutta P, Rasaily R, Saha MR et al. Randomized clinical trial of furazolidone for typhoid fever in children. Scand J Gastroenterol 1993; 28: 168-72.
40. Gasem MH, Keuter M, Dolmans WMV et al. Persistence of salmonellae in blood and bone marrow: randomized controlled trial comparing ciprofloxacin and chloramphenicol treatments against enteric fever. Antimicrob Agents Chemother 2003; 47: 1727-31.
41. Gotuzzo E, Echevarra J, Carrillo C et al. Randomized comparison of aztreonam and chloramphenicol in treatment of typhoid fever. Antimicrob Agents Chemother 1994; 3: 558-63.
42. Kaye D, Rocha H, Eyckmans L et al. Comparison of parental ampicillin and parental chloramphenicol in the treatment of typhoid fever. Ann N Y Acad Sci 1967; 145: 423-8.
43. Lasserre R, Sangalang RP, Santiago L. Three-day treatment of typhoid fever with two different doses of ceftriaxone, compared to 14-day therapy with chloramphenicol: a randomized trial. J Antimicrob Chemother 1991; 28: 765-72.
44. Huys J, Freyens P, Kayihigi J et al. Treatment of epidemic typhus. A comparative study of chloramphenicol, trimethoprim-sulphamethoxazole and doxycycline. Trans R Soc Trop Med Hyg 1973; 67: 718-21.
45. Memon IA, Billoo AG, Memon HI. Cefixime: an oral option for the treatment of multidrug-resistant enteric fever in children. South Med J 1997; 90: 1204-7.
46. Omer Ali MI. Trimethoprim sulphamethoxazole in the treatment of enteric fever. J Trop Med Hyg 1975; 78: 162-6.
47. Rabbani MW, Iqbal I, Malik MS. A comparative study of cefixime and chloramphenicol in children with typhoid fever. J Pak Med Assoc 1998; 48: 163-4.
48. Phongmany S, Phetsouvanh R, Sisouphone S et al. A randomized comparison of oral chloramphenicol versus ofloxacin in the treatment of uncomplicated typhoid fever in Laos. Trans R Soc Trop Med Hyg 2005; 99: 451-8.
49. Arjyal A, Basnyat B, Koirala S et al. Gatifloxacin versus chloramphenicol for uncomplicated enteric fever: an open-label, randomised, controlled trial. Lancet Infect Dis 2011; 11: 445-54.
50. Sardesai HV, Karandikar RS, Harshe RG. Comparative trial of co-trimoxazole and chloramphenicol in typhoid fever. Br Med J 1973; 1: 82-3.
51. Sarma PSA, Durairaj P. Randomized treatment of patients with typhoid and paratyphoid fevers using norfloxacin and chloramphenicol. Trans R Soc Trop Med Hyg 1991; 85: 670-1.
52. Scioli C, Giusti G, Balestrieri G. Comparison of ampicillin and chloramphenicol in treatment of typhoid fever. Postgrad Med J 1964; 40: 87-97.
53. Tatli MM, Aktas G, KosecikMet al. Treatment of typhoid fever in children with a flexible-duration of ceftriaxone, compared with 14-day treatment with chloramphenicol. Int J Antimicrob Agents 2003; 21: 350-3.
54. Snyder MJ, Perroni J, Gonzalez O et al. Trimethoprim-sulfamethoxazole in the treatment of typhoid and paratyphoid fevers. J Infect Dis 1973; 128: 734-7.
55. Snyder MJ, Gonzalez O, Palomino C et al. Comparative efficacy of chloramphenicol, ampicillin, and co-trimoxazole in the treatment of typhoid fever. Lancet 1976; 2: 1155-7.
56. Islam A, Butler T, Kabir I et al. Treatment of typhoid fever with ceftriaxone for 5 days or chloramphenicol for 14 days: a randomized clinical trial. Antimicrob Agents Chemother 1993; 37: 1572-5.
57. Islam A, Butler T, Nath SK et al. Randomized treatment of patients with typhoid fever by using ceftriaxone or chloramphenicol. J Infect Dis 1988; 158: 742-7.
58. Quintero-Perez. Comparative double blind efficacy and safety study of ciprofloxacin with chloramphenicol in the treatment of typhoid fever. In: Abstracts of the Twenty-eighth Interscience Conference on Antimicrobial Agents and Chemotherapy, Los Angeles, CA, USA, 1988. Abstract 385. American Society for Microbiology, Washington, DC, USA.
59. Moosa A, Rubidge CJ. Once daily ceftriaxone vs. chloramphenicol for treatment of typhoid fever in children. Pediatr Infect Dis J 1989; 8: 696-9.
60. Tanaka-Kido J, Ortega L, Santos JI. Comparative efficacies of aztreonam and chloramphenicol in children with typhoid fever. Pediatr Infect Dis J 1990; 9: 44-8.
61. Girgis NI, Farid Z, Kilpatrick ME et al. Aztreonam compared to chloramphenicol in the treatment of enteric fevers. Drugs Exp Clin Res 1992; 18: 197-9.
62. Girgis NI, Kilpatrick ME, Farid Z et al. Ceftriaxone versus chloramphenicol in the treatment of enteric fever. Drugs Exp Clin Res 1990; 16: 607-9.
63. Gupta SP, Chugh TD, Kapoor P. A double blind study of chloramphenicol, furazolidine and combination regimens in enteric fevers. J Assoc Physicians India 1978; 26: 573-6.
64. Thiruvengadam KV, Haranath K, Devarajan TV et al. The efficacy of epicillin in enteric fever (a comparative study with that of chloramphenicol). J Assoc Physicians India 1977; 25: 709-14.
65. Ramachandran S, Godfrey JJ, Lionel ND. A comparative trial of co-trimoxazole and chloramphenicol in thyphoid and paratyphoid fever. J Trop Med Hyg 1978; 81: 36-9.
66. Mahapatra GB, Broacha ER, Toprani HT. Enteric fevers in children-a prospective study on comparative evaluation of three drugs (chloramphenicol, furazolidone and co-trimethoxazole). Indian Pediatr 1979; 16: 259-65.
67. Hassau A, Sippel J, Farid Z et al. A comparative study of epicillin and chloramphenicol in the treatment of enteric fever. J Int Med Res 1977; 5: 91-5.
68. Punjani MK, Anand JS. A comparative study of chloramphenicol and furazolidone in the treatment of typhoid fever in children. Indian Pediatr 1978; 15: 769-76.
69. Hassan A, Hathout S, Safwat Y et al. A comparative evaluation of the treatment of typhoid fevers with co-trimoxazole and chloramphenicol in Egypt. J Trop Med Hyg 1975; 78: 50-3.
70. Abejar NH, Dimaano EM, Cabanban AB et al. Comparative study of fleroxacin vs. chloramphenicol in typhoid fever at San Lazaro Hospital. Phil J Microbiol Infect Dis 1993; 22: 8-10.
71. Abejar NH, Dimaano EM, Cabanban AB. Fleroxacin vs chloramphenicol in enteric fever. An open, randomized, parallel study. Phil J Intern Med 1993; 6: 327-30.
72. Salgado MR, Lionel ND. A comparative trial of furazolidone and chloramphenicol in typhoid and paratyphoid fever. Ceylon Med J 1970; 15: 159-62.
73. Uwaydah M, Matossian R, Balabanian M. Co-trimoxazole compared to chloramphenicol in the treatment of enteric fever. Scand J Infect Dis 1975; 7: 123-6.
74. Samantaray SK, Johnson SC, Chakrabarti AK. Comparative clinical trial of co-trimoxazole, furazolidone and chloramphenicol in enteric fever. J Assoc Physicians India 1975; 23: 577-83.
75. Morelli G, Mazzoli S, Tortoli E et al. Fluoroquinolones versus chloramphenicol in the therapy of typhoid fever: a clinical and microbiological study. Curr Ther Res Clin Exp 1992; 4: 532-42.
76. Siasoco RE, Hipolito EF. A comparison of the efficacy of trimethoprimsulfamethoxazole (Bactrim) and chloramphenicol in the treatment of typhoid fever. Phil J Microbiol Infect Dis 1973; 2: 39-45.
77. Cascio A, Colomba C, Di Rosa D et al. Efficacy and safety of clarithromycin as treatment for Mediterranean spotted fever in children: a randomized controlled trial. Clin Infect Dis 2001; 33: 409-11.
78. WHO. Standardized Treatment of Bacterial Meningitis in Africa in Epidemic and Non Epidemic Situations. Geneva: WHO. http://www.who. int/csr/resources/publications/meningitis/WHO_CDS_EPR_2007_3.pdf.
79. WHO. Background Document: The Diagnosis, Treatment and Prevention of Typhoid Fever. Geneva: WHO. http://whqlibdoc.who.int/hq/2003/WHO_V&B_03.07.pdf.
80. Fluit AC, Wielders CLC, Verhoef H et al. Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY study. J Clin Microbiol 2001; 39: 3727-32.
81. Nitzan O, Suponitzky U, Kennes Y et al. Is chloramphenicol making a comeback? Isr Med Assoc J 2010; 12: 371-4.
82. Lautenbach E, Schuster MG, Bilker WB et al. The role of chloramphenicol in the treatment of bloodstream infection due to vancomycin-resistant Enterococcus. Clin Infect Dis 1998; 27: 1259-65.
83. Papanicolaou GA, Meyers BR, Meyers J et al. Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality. Clin Infect Dis 1996; 23: 760-6.
84. Livermore DM, Warner M, Mushtaq S et al. What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline. Int J Antimicrob Agents 2011; 37: 415-9.